Director/PDMR Share Dealings

February 13, 2015

Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”) announces that it has been notified today that Ordinary Shares (“Shares”) and American Depositary Shares (“ADSs”) of the Company, as set out below, have been awarded to Persons Discharging Managerial Responsibilities (“PDMRs”) today under the Shire Executive Annual Incentive Plan (“EAIP”) and under deferred stock arrangements related to Shire’s annual bonus plan (“Deferred Bonus”). The Shares and ADSs were acquired today at prices of £50.10 per Share and $233.639 per ADS on the London Stock Exchange and NASDAQ respectively.

PDMR

Award Arrangement

Type of Security

Number of Securities

 

Flemming Ornskov

 

EAIP

 

ADSs

 

2,501

 

Tatjana May

 

EAIP

 

Shares

 

1,744

 

Mark Enyedy

 

Deferred Bonus

 

ADSs

 

455

 

Ginger Gregory

 

Deferred Bonus

 

ADSs

 

330

 

Philip Vickers

 

Deferred Bonus

 

ADSs

 

450

 

The awards will normally be released to PDMRs after a period of three years. One ADS is equal to three Shares.

This notification relates to disclosures made in accordance with 3.1.4(R)(1)(a) of the Disclosure and Transparency Rules.

Tony Guthrie
Deputy Company Secretary

For further information please contact:

Investor Relations

Sarah Elton-Farr
seltonfarr@shire.com
+44 1256 894157

NOTES TO EDITORS

Shire enables people with life-altering conditions to lead better lives.

Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.

We focus on providing treatments in Rare Diseases, Neuroscience, Gastrointestinal and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmics.

www.shire.com

Click here for the PDF version of this press release.